CT scanning, a promising approach to detecting lung cancer at early, treatable stages, has been dealt a setback with the revelation that the most prominent study so far in support of it was funded almost entirely by a cigarette company—with the funds funneled through a foundation set up by the study’s author, Dr. Claudia Henschke, reports the New York Times. Although the funding revelation doesn’t negate the results of the study, it raises huge conflict of interest flags and reveals how a tobacco company secretly influenced professional opinion by funneling $3.6 million into the foundation over a three year period.
